BRD7P6

Across TCGA pan-cancer cohorts, BRD7P6 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated BRD7P6 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher BRD7P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BRD7P6 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

UVM, THCA, and LUSC are the cancer types where BRD7P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	II,III,IV	0.213	0.718	.002	81	view →
THCA	OS	Tertile	III,IV	0.556	0.858	<.001	63	view →
LUSC	DFS	Quartile	III,IV	0.369	0.723	<.001	54	view →
DLBC	OS	Tertile	III,IV	0.154	0.735	.010	52	view →
ACC	OS	Tertile	All	0.121	0.631	.007	36	view →
LIHC	OS	Tertile	III,IV	0.051	0.616	<.001	33	view →
COAD	DFS	Tertile	II,III,IV	0.165	0.477	.006	30	view →
CESC	OS	Tertile	II,III,IV	0.562	0.788	.017	24	view →
ESCA	DFS	Tertile	All	0.388	0.583	.006	18	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	18	view →
LUAD	DFS	Tertile	IV	0.461	0.757	.035	18	view →
LGG	OS	Tertile	All	0.192	0.528	.017	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

BRD7P6–UVM (OS)

Open the UVM breakdown →